Internal Medicine, Hematology & Oncology · Columbus, OH
NPI
1538127238
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3100 Plaza Properties Blvd
Columbus, OH, 43219
Phone (614) 383-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$523K
36,299 services
Medicare patients, 2024
260
Average age 75
Drug cost, 2024
$1.9M
810 prescriptions
Company payments, 2025
$3,708
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Poongothai Sundaram was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 4,200 times for 29 patients. In total Poongothai Sundaram billed 36,299 services in 112 codes, and Medicare paid $523K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,200 | 29 | $0.11 | $441 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,400 | 11 | $15.57 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 680 | 12 | $0.09 | $60.94 |
| 85025 Blood Count | Office | 565 | 193 | $7.59 | $4,288 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 440 | 11 | $0.72 | $316 |
| 36415 Venipuncture Blood Collection | Office | 439 | 178 | $8.53 | $3,747 |
| 99214 Office E&M - Established | Office | 282 | 131 | $88.26 | $25K |
| 96372 Injection Administration | Office | 195 | 28 | $9.75 | $1,902 |
| 99213 Office E&M - Established | Office | 139 | 105 | $62.49 | $8,686 |
| 96375 Injection Administration | Office | 126 | 13 | $10.99 | $1,385 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 106 | 19 | $76.92 | $8,154 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 98 | 12 | $0.83 | $81.33 |
| 96413 Chemotherapy Administration | Office | 94 | 17 | $91.03 | $8,557 |
| 96367 Intravenous Infusion, Hydration | Office | 83 | 14 | $20.13 | $1,671 |
| 85045 Blood Count | Office | 36 | 27 | $3.89 | $140 |
By year: 2022 $1.0M for 58,624 services; 2023 $974K for 49,447 services; 2024 $523K for 36,299 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 565 | 193 | $7.59 | $4,288 |
| 36415 Venipuncture Blood Collection | 439 | 178 | $8.53 | $3,747 |
| 85045 Blood Count | 36 | 27 | $3.89 | $140 |
Medicare prescription drug claims, 2024
In 2024, the drug Poongothai Sundaram prescribed most often to Medicare patients was Letrozole, with 143 prescriptions and refills. In total Poongothai Sundaram wrote 810 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 143 | 307 | 40 | $2,286 |
| Hydroxyurea Generic | 51 | 97 | 18 | $1,002 |
| Eliquis Apixaban | 46 | 50 | Under 11 | $28K |
| Prochlorperazine Maleate Generic | 42 | 42 | 28 | $697 |
| Exemestane Generic | 34 | 60 | Under 11 | $9,340 |
| Anastrozole Generic | 34 | 102 | 16 | $1,115 |
| Dexamethasone Generic | 32 | 32 | Under 11 | $421 |
| Tamoxifen Citrate Generic | 29 | 65 | Under 11 | $1,149 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 21 | 21 | 14 | $241 |
| Revlimid Lenalidomide | 21 | 21 | Under 11 | $301K |
| Imatinib Mesylate Generic | 19 | 21 | Under 11 | $10K |
| Danazol Generic | 18 | 18 | Under 11 | $5,612 |
| Ibrance Palbociclib | 18 | 18 | Under 11 | $249K |
| Sertraline Hcl Generic | 15 | 23 | Under 11 | $55.39 |
| Acyclovir Generic | 14 | 34 | Under 11 | $198 |
Brand drugs: 188 claims; generic drugs: 622 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Poongothai Sundaram $3,708 ($3,708 in general payments such as food, travel and fees) from 24 companies. The largest payer was Daiichi Sankyo Inc. with $1,589.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 3 | $1,589 |
| Geron Corporation GERN | 1 | $780 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $407 |
| Gilead Sciences, Inc. GILD | 4 | $109 |
| Pfizer Inc. PFE | 4 | $103 |
| Eisai Inc. 4523.T | 3 | $81.71 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $66.01 |
| Array Biopharma Inc PFE | 3 | $60.22 |
| Abbvie Inc. ABBV | 2 | $52.78 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $51.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.